Stocktoria
Zepp Health Corp ZEPP
Zepp Health Corp financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $258.9M | $182.6M | $2.5B | $4.1B | $6.3B | $6.4B | $5.8B | $3.6B | $2.0B | $1.6B |
| Gross profit | $99.2M | $70.2M | $92.4M | $118.9M | $204.9M | $204.2M | $210.8M | $136.6M | $76.0M | $276.2M |
| R&D expense | $45.3M | $46.2M | $51.5M | $77.3M | $80.8M | $82.5M | $61.9M | $38.3M | $23.6M | $132.3M |
| Operating income | -$29.2M | -$47.2M | -$30.4M | -$61.9M | $14.7M | $26.7M | $87.1M | $53.2M | $28.0M | $13.4M |
| Interest expense | — | — | $6.7M | $8.3M | $7.0M | $22.6M | — | — | — | — |
| Income tax | $2.5M | $13.7M | -$2.4M | -$9.9M | $1.7M | $4.8M | $11.2M | $7.6M | $4.2M | $3.1M |
| Net income | -$40.1M | -$75.7M | -$31.0M | -$43.2M | $21.6M | $35.1M | $82.6M | $49.5M | $25.8M | $23.9M |
| EPS (diluted) | $-0.16 | $-0.29 | $-0.13 | $-0.18 | $0.08 | $0.13 | $0.32 | $0.07 | $0.10 | $-0.22 |
| Operating cash flow | -$25.7M | -$24.4M | $42.6M | -$117.1M | -$36.5M | $24.1M | $61.5M | $102.9M | $36.6M | $17.3M |
| Free cash flow | -$26.2M | -$25.8M | $41.0M | -$118.3M | -$43.7M | $11.3M | $56.6M | $100.4M | $33.3M | $7.0M |
| Cash & equivalents | $57.0M | $91.1M | $133.7M | $128.6M | $230.4M | $348.4M | $259.0M | $209.7M | $56.3M | $153.2M |
| Inventory | $72.8M | $56.8M | $84.9M | $148.2M | $196.0M | $186.6M | $128.4M | $70.5M | $38.4M | $192.4M |
| Total assets | $564.8M | $528.6M | $635.5M | $763.7M | $955.0M | $904.8M | $743.3M | $473.9M | $225.2M | $972.9M |
| Total liabilities | $350.3M | $275.9M | $282.8M | $374.5M | $494.6M | $486.4M | $384.6M | $210.7M | $136.4M | $634.4M |
| Shareholders' equity | $214.5M | $252.7M | $352.8M | $389.3M | $460.3M | $418.4M | $359.2M | $263.4M | $35.1M | $30.2M |
Growth · year-over-year · Revenue CAGR -18.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +41.8% | -92.7% | -39.8% | -33.7% | -2.8% | +10.7% | +59.4% | +77.9% | +31.6% | — |
| Net income growth | — | — | — | -300.0% | -38.3% | -57.6% | +67.1% | +91.9% | +7.6% | — |
| EPS growth | — | — | — | -325.0% | -38.5% | -59.4% | +357.1% | -30.0% | — | — |
| Free cash flow growth | — | -162.9% | — | — | -486.7% | -80.0% | -43.7% | +201.3% | +376.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.